Frank Shannon

Mr. Frank Shannon has a track record of more than 25 years of proven experience in clinical development and regulatory affairs. He has served in senior-level positions within the international medical device, pharmaceutical, and biologic industries ,where he achieved commercial goals through innovative risk management and execution strategies to obtain marketing approval of products.

Mr. Shannon most recently served as Vice President, Clinical Development, Regulatory Affairs and Quality, at Ripple Therapeutics, a spin-out of Interface Biologics, where he had served in the same capacity since 2016. Prior to these appointments, he held various senior clinical/regulatory positions at Baxter International, St. Jude Medical, Boehringer Ingelheim, Hoffmann-La Roche/Roche Laboratories, Inc., Genentech Canada, Inc., and Ciba-Geigy Canada, Ltd.